← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× Epigenetic Priming Ketone
HDAC2/HDAC3 · metabolic-neuroscience · -
Composite 0.661
Price $0.60
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Epigenetic Priming Ketone Protocol starts from the claim that modulating HDAC2/HDAC3 within the disease context of metabolic neuroscience can redirect a disease-relevant process. The original description reads: "## **Molecular Mechanism and Rationale** The epigenetic priming ketone protocol leverages the dual functionality of β-hydroxybutyrate as both a metabolic substrate and an epigenetic modulator, specifically targeting class I histone deacetylases (HDACs) to enhance
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Epigenetic Priming Ketone Prot Mechanistic 0.747 Evidence 0.600 Novelty 0.748 Feasibility 0.690 Impact 0.644 Druggability 0.900 Safety 0.600 Competition 0.800 Data 0.700 Reproducible 0.456 KG Connect 0.199
Evidence Epigenetic Priming Ketone Protocol No evidence citations yet
Price History Overlay
Knowledge Graph Comparison
Epigenetic Priming Ketone Protocol
52 edges
Top Node Types process 15
protein 12
gene 6
mechanism 6
drug 6
Top Relations causes 14
regulates 9
activates 5
inhibits 5
risk_factor_for 4